Periscope Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Periscope Capital’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-458,619	Closed	-$4.7M	–	790
2023 Q1	$4.7M	Sell	458,619 -12,952	-3%	-$131K	0.22%	159
2022 Q4	$4.74M	Buy	471,571 +300	+0.1%	+$2.99K	0.2%	191
2022 Q3	$4.64M	Sell	471,271 -127,929	-21%	-$1.26M	0.13%	304
2022 Q2	$5.83M	Hold	599,200	–	–	0.16%	260
2022 Q1	$5.84M	Sell	599,200 -300	-0.1%	-$2.91K	0.15%	269
2021 Q4	$5.85M	Buy	+599,500	New	+$5.88M	0.16%	259

Periscope Capital's ORIA Position: Q2 2023 in Review

Periscope Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 458,619 shares — an estimated $4.7M sold.

Periscope Capital first reported a position in ORIA in Q4 2021 and held it in 6 quarters. The position peaked at $5.85M in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Periscope Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Periscope Capital sold 458,619 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $4.7M.
Periscope Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 6 quarters.
Periscope Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $5.85M in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Periscope Capital's 13F filing for Q2 2023, filed 14 Aug 2023.